$TRON "Theorizing a 48M/26M Hedge and Improving Lending by

New Post Public Reply Private Reply Replies (1) Message Board
Mysterium
578
$TRON "Theorizing a 48M/26M Hedge and Improving Lending by Hedging Restricted Shares Against a Series of Acquisition Loans:


Playing the Hedge:

48M bought at .0055 and 26M shorted. On the premise one wanted to hedge and sway a low-floater, this theory came to mind the other day and I thought I would share it in case anyone is interested and/or likes to prepare for "best case/worst case scenarios".

48,000,000 x .0055 = 264,000

If an entity wanted to drive the price up and drop it hard, knowing full well that the book value would be far higher than the price they drove it down to, this is how they could potentially play it to create profit and panic, and more profit on the second return.

Purchase 48M for $264k, push the stock up to triple the price without selling.

$264,000 x 3 = $792,000
.0055 x 3 = .0165pps

$264,000 / .0165 = 16M shares to recoup initial investment

48M - 16M = 32M free shares left

Slow bleed the 16M out near the top and recoup the 264, then sell 32M downward in timed increments, causing fear and doubt, and thus panic selling; and then while profiting at any price by selling the free 32M shares acquired, next thing you know is the pps is down to .0055 where the short position was entered and covering begins below .0055 before driving the price back up, picking up cheap shares along the way on panic.

Eventually the book value catches up and the stock won't trade below that value, but in a worst case manipulation, this is one theory on how the market makers or traders could use a hedge to manipulate a swing. This is being depicted to avoid panic or hopelessness for the long-term holders.

Best case scenario is that it was a long or a company insider that purchased the 48M and someone tried to short against it, leaving them in need of covering. This would create a very solid holding and a potential short squeeze in tandem. Rocket fuel.

On the premise that the company comes out with the 8k, and all of the numbers are within the expected range(s), then don't get shaken if an entity is playing with the gloves off right when the company has its best moment to date and shows definitive proof. The company can only influence the price by book value of its deals, or by the number of press releases it puts out. And while sometimes we are in the dark, I happen to like that Rene never pumps the stock. He goes to work building the company and gives info when it is available. I'd rather have a CEO that builds value, leading to a sustained climb, than one that knows how to dangle the carrot and influence the price via emotions, which is obviously an unsustainable method and return.




How Lending Could Become Better and Easier in the Future(Another Hedge):

InMed was acquired for $10.9M and 100M shares went to both InMed and Flagship. Flagship is the lender, so I will be predominantly referencing Flagship and their 100M shares going forward, while InMed is the product and driver on returns(both for Toron and InMed).

100M shares are given to Flagship in exchange for $10.9M to Toron for the purchase and acquisition of InMed; and for sake of simplicity, I am going to use .01 as the starting price per share.

For every 100M shares Flagship owns at .01, they yield $1M in share equity. Seeing as InMed is estimated to have +$100M in revs, it would be obvious that a .10 book value would be warranted(*understatement!). With a .10 book value, Flagship would now have $10M in share equity. And with InMed's revs, Toron could potentially pay Flagship back $3.63M/yr for 3yrs, by which time Flagship has almost doubled their money, making $10M profit off a $10.9M loan, with $20.9M in hand once the terms and payments are fully satisfied.

Using this model, if Flagship then lends another $10M for a similar acquisition, then in the case of all things being linear, the pps goes from .10-.20, leaving Flagship with $20M in share equity alone, while being paid from InMed. This makes things easier for Toron.

Now Toron could use annual profits from both InMed and the similar up-and-coming acquisition to pay back Flagship for the first loan, which could then be satisfied in full within 2yrs or less, provided that the $3.63M still comes from InMed, with additional profits from the future deal paying for InMed as well.

Once the InMed loan is paid, InMed can then assist in paying for the new acquisition, and each series of funding gets paid off faster and faster, with Flagship making $10M in equity every ten cents Toron climbs in share price, seeing as multiple acquisitions would be paying off a singular loan for each future acquisition, thus creating a scenario in which each $10M loan is paid off faster and faster. InMed's 100M shares also look nice, adding to their value under Toron's umbrella with each ten cent hike as well. InMed could get its own acquisition lending, while Toron uses InMed's value to leverage funding simultaneously.

So Flagship just keeps rolling over $10M to make $20M, and Toron climbs with each acquisition. And as each $10M loan is paid back, Toron wipes the balance sheet clean, becoming debt free every couple of years, with each acquisition improving the debt to asset ratio, with debt always maxing out around the $10M mark. Finally, above $1.00pps, lending becomes increasingly easier to find, and with better terms, while large institutions and retail investors become more fond of the increased safety of the stock, leading to swaths of new buyers(traders and investors alike). This pushes the price and creates increasing value for Flagship, making it a very favorable scenario to increase lending amounts, as their stock equity would be $100M, and now they could hedge $20M loans each time instead of $10M, with $80M hedged against $20M out the door, with multiple profitable acquisitions paying off the singular loan rather than just a one-for-one.


In closing, I do not know if either of these scenarios are accurate or are in play, but the double hedge theory has been crossing my mind for the past few days, so I wanted to get it out on paper(so to speak).

Whether the price goes up or down on the 8k or the run to follow, all that matters to me are the numbers that are in it. If the numbers are there, the price per share will eventually adjust to meet those numbers. Book value is book value.

ALL THINGS MOBILE ANALYTIC INC. (ATMH) Stock Research Links

ATMH Board Company Profile Buy Rating Time & Sales News Filings Financials
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 2

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Updated Category News Views 3

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 1

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
South Florida Donor Network Honors 52 Heroic Donors

Updated Category News Views 2

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 2

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Strategic Hire: Whisenhunt Joins FlexScreen & RiteScreen

Updated Category News Views 2

Shaking Up the Window Screens Biz If you've been grinding in the window and door game, you know it's not an industry with a lot of buzz, but here comes a shot of caffeine. FlexScreen and RiteScreen just snagged David Whisenhunt to rev up their sales machine. Who's David Whisenhunt? Well, he's no rookie. With over two decades deep in the fenestration field, Whisenhunt...

Continue Reading
AI Startup Shuttlebase Navigates Name Clash with Change

Updated Category News Views 6

When Two AI Giants Collide Every so often, we get a clash of titans in the business world, and this time it's in the AI universe. New York's Moonshot AI, a champ in autonomous website optimization, hit a bump when its name collided with a Chinese counterpart, also called Moonshot AI. And just like that, the NY company had to chuck their name out the window and don a new...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 0

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading
Law Firm Gains Strength with Strategic New Hires

Updated Category News Views 0

Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....

Continue Reading

Top 5 Most Recently Viewed Articles

Four Seasons Education Sees Notable Growth in First Half FY26

Updated Category News Views 138

Four Seasons Education Financial Results Overview Four Seasons Education (Cayman) Inc. (NYSE: FEDU), a provider of education and tourism-related services, has revealed its unaudited financial results for the first half of the fiscal year 2026, celebrating significant improvements across various metrics. Key Financial Highlights The company experienced a strong revenue...

Continue Reading
Balchem Corporation's Strong Q3 2025 Financial Report Insights

Updated Category News Views 165

Overview of Balchem Corporation's Q3 2025 Financial Performance Balchem Corporation (NASDAQ: BCPC) has recently showcased an impressive financial performance for its third quarter of fiscal 2025, revealing remarkable sales growth and significant earnings improvements. Third Quarter 2025 Financial Highlights For the third quarter ended September 30, 2025, Balchem reported...

Continue Reading
Exciting Opportunities: Formula 100's New Test Team Program

Updated Category News Views 132

Exciting Launch of the Formula 100 Test Team Program Formula 100, a leader in precision bike care products, is thrilled to announce its newly established Formula 100 Test Team. The launch took place during a dynamic event that celebrated all things cycling. The team's formation allows passionate riders to influence the future of bike care products, working closely with...

Continue Reading
Renewed Lease Agreement for La Méditerranée Supports Community Growth

Updated Category News Views 135

Renewed Commitment to Local Communities Recent developments around the Upper Fillmore Revitalization Project highlight the vitality of community-focused initiatives. La Méditerranée, a beloved local restaurant, has announced an exciting extension of its lease at its Fillmore Street location, ensuring its presence in the neighborhood through the summer of 2028. Support...

Continue Reading
Matson, Inc. Reports Exceptional Fourth Quarter Earnings

Updated Category News Views 75

Exceptional Financial Performance in Fourth Quarter Matson, Inc. announced impressive fourth quarter results for 2024, reporting earnings per share (EPS) of $3.80. This marks a noteworthy increase from the previous year. Full Year Review and Key Metrics For the entire year of 2024, the company achieved a full-year EPS of $13.93. Net income reached a remarkable $476.4...

Continue Reading